Discover how The US Oncology Network leverages AI to reduce provider burden, extract clinical data and improve patient outcomes.
Accelerating Care Through Our Oncology Ecosystem
In the first installment of our Always Advancing series, McKesson leaders share how our unified oncology ecosystem is accelerating access to care, improving outcomes and driving innovation in cancer research.
Read Time
3.5 minutes
Jason Hammonds, chief operating officer, Oncology & Multispecialty; Michelle Lockyer, chief strategy officer, Oncology; and Dee Anna Smith, chief executive officer, Sarah Cannon Research Institute, highlight our shared commitment to advancing precision medicine, clinical research and real-world evidence.
Accelerating Care Through Our Oncology Ecosystem
About Always Advancing:
From navigating the stages of research and development and engaging diverse populations in clinical trials to enabling patient access to prescribed therapies and beyond, the healthcare landscape has never been more complex or more promising for improving the lives of patients. Our Always Advancing series shares how we help our biopharma partners bridge the divide between today’s challenges and tomorrow’s breakthroughs so more patients can get the care they need.
Related Stories
At Biologics by McKesson, proactive pharmacy care and personalized support help patients stay on therapies, reduce costs and improve outcomes.
How McKesson connects biopharma, providers and patients to deliver precision oncology at scale through integrated logistics, specialty pharmacy and high‑touch support.
Sarah Cannon Research Institute (SCRI) offers clinical trials in communities close to home, where 85% of patients seek care.
How Shenandoah Oncology became a blueprint for compassion and turned patient feedback into a lifeline.
How community oncology clinics are helping break down barriers to care.
How Biopharma and community oncology are working together to solve healthcare’s toughest challenges and build a more resilient future for cancer care.
Meeting the demands of ultra-sensitive treatments with purpose-built storage, automation and pharmacy integration
In the third episode of our Always Advancing video series, learn how precision and personalized medicine are transforming cancer care – expanding access to clinical trials and novel treatments in communities.
Using McKesson Compile’s analytics to transform how patients with rare blood disorders access specialized care across Indiana.